Anlon Healthcare 13th AGM Approves Preferential Share Issuance

Meeting Details

Date: Saturday, September 05, 2025
Time: 11:00 A.M. IST (commenced at 11:10 A.M., concluded at 11:50 A.M.)
Location: Conducted through Video Conference (VC)/Other Audio-Visual Means (OAVM) facility
Type of Meeting: 13th Annual General Meeting

Attendance

Total Members Present: 31 members
Directors and Key Managerial Personnel in Attendance:
Mr. Punitkumar Rameshbhai Rasadia, Chairman cum Managing Director (DIN: 06696258)
Mr. Meet Atulkumar Vachhani, Whole Time Director
Ms. Mamata Punitkumar Rasadia, Director
Mr. Krishna Murty Kannepalli, Non-Executive and Independent Director
Mr. Anandbhai Natwerlal Katkoria, Non-Executive and Independent Director
Mr. Kishan Vinodkumar Raja, Non-Executive and Independent Director
Ms. Amita Chhaganbhai Pragada, Company Secretary & Compliance Officer
Other Representatives: Mr. Parth Sanjaybhai Udani (Internal Auditor), M/s R V D & Co. (Statutory Auditor), M/s K. P. Ghelani & Associates (Secretarial Auditor and Scrutinizer)

Summary of Proceedings

Mr. Naimish Bhatt, Chief Financial Officer, welcomed members and introduced the Board. Mr. Punitkumar Rameshbhai Rasadia was confirmed as Chairman of the meeting. The Chairman addressed shareholders with an introductory speech and provided an overview of the company's operations and financial performance for the year 2025-2026.

Seven members registered as speakers and raised questions before the Board. The Chairman responded to queries on behalf of the Board/Management, with requests for detailed follow-up via email where necessary.

M/s K. P. Ghelani & Associates, Practicing Company Secretary, was appointed as Scrutinizer for conducting the e-voting process. Results for remote e-voting and e-voting during the AGM were to be placed on the company website and submitted to stock exchanges.

Business Considered

Ordinary Business

Item No.1: To receive, consider and adopt the Audited Standalone Financial Statements for the financial year ended March 31, 2026, together with reports of the Board of Directors and Auditors
Item No.2: To receive, consider and adopt the Audited Consolidated Financial Statements for the financial year ended March 31, 2026, together with reports of the Board of Directors and Auditors

Special Business

Item No.3: To appoint a director in place of Mr. Punitkumar Rameshbhai Rasadia (DIN: 06696258) who retires by rotation and offers himself for re-appointment (Ordinary Resolution)
Item No.4: To appoint Mr. Kishan Vinodkumar Raja (DIN: 11522235) as a Non-Executive & Independent Director (Ordinary Resolution)
Item No.5: To approve remuneration of Cost Auditor of the Company (Ordinary Resolution)
Item No.6: Enhancement of Authorized Share Capital (Ordinary Resolution)
Item No.7: Alteration of Capital Clause contained in the Memorandum of Association (Special Resolution)
Item No.8: Approval for issuance of 8,58,83,617 Equity Shares of the Company on preferential basis for consideration other than cash to the shareholders of Apiqo Organics Private Limited and Bizotic Lifescience Private Limited (Special Resolution)
Item No.9: Material Related Party Transactions between Apiqo Organics Private Limited and the Company (Ordinary Resolution)
Item No.10: Material Related Party Transactions between Bizotic Lifescience Private Limited and the Company (Ordinary Resolution)
Item No.11: Material Related Party Transactions between Anlon Medicos Private Limited (formerly Known As Remember India Health Links Private Limited) and the Company (Ordinary Resolution)

Voting Process

The e-voting process was conducted by M/s K. P. Ghelani & Associates as Scrutinizer. The results were to be published on the company website and submitted to stock exchanges as per applicable provisions of the Companies Act and listing regulations.

Auditor Reports

The report of the Statutory Auditor and Secretarial Auditor were taken as read and noted to contain no qualifications, observations, or adverse remarks.

Compliance Confirmation

The meeting was conducted in compliance with the provisions of the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as permitted by the Ministry of Corporate Affairs (MCA) and Securities and Exchange Board of India (SEBI).